Search for: "Bexis"
Results 321 - 340
of 403
Sorted by Relevance
|
Sort by Date
20 Nov 2008, 10:19 am
This is a practical - some would say, impractical - post. [read post]
12 May 2009, 12:38 pm
Bexis put together this amendment. (3) fixing some lingering problems in the choice of law section ( §2.05) including the longstanding issue of whether there's a principal-place-of-business rule that would allow plaintiffs all over the country to sue under the law of a single state. [read post]
28 Feb 2008, 8:39 am
A little over a week ago (in other words, an eternity in the blogosphere), the FDA announced new draft guidelines that slightly relaxed some aspects of the Agency's prohibitions concerning promotion of off-label uses by manufacturers of FDA-regulated products. [read post]
14 Jan 2010, 10:51 am
Usually, they’d rather settle.That’s why Bexis wrote the 1998 article, and then followed with dozen or so amicus briefs on the same issues in most of the cases that we've cited. [read post]
23 Jul 2009, 3:15 am
Astrazeneca Pharmaceuticals LP), because of Bexis' firm's involvement in the litigation (although not this aspect). [read post]
10 Dec 2009, 12:05 pm
The amicus brief that Bexis filed for the WLF in the Caputo case looked into Medicare reimbursement of off-label uses as one example of the government's Dr. [read post]
6 Dec 2010, 11:34 am
Bexis drafted them, and the ALI accepted them. [read post]
18 Apr 2007, 10:06 pm
Just look in Bexis' book, for one thing. [read post]
2 Feb 2010, 7:28 am
If our plaintiff keeps this up, that’s probably going to force us to look for those cases at some point.But since we’re about drugs and devices, we turn to Bexis’ book, where we find loads of precedent holding that subsequent changes in drug labeling, and other FDA actions (such as recalls) are considered subsequent remedial measures: Chlopek v. [read post]
28 Jun 2010, 3:50 am
(Disclosure: Bexis wrote much of the WLF amicus brief on this issue, so it's not as if we're disinterested.)There have been tens of thousands of cases filed claiming that atypical antipsychotics, such as Risperdal, aren't all they're cracked up to be and that they can cause weight gain and diabetes. [read post]
10 Feb 2012, 8:39 am
Pa. 1995) (one of Bexis’ first medical device cases). [read post]
28 Dec 2011, 1:13 pm
Unfortunately Prednisone is well-know among those who prescribe and use it (such as Bexis’ daughter, for a while) for causing adverse reactions approximately 100% of the time. [read post]
30 Dec 2007, 8:03 am
(Mein Gott, Bexis, what are you doing? [read post]
6 Sep 2007, 8:13 am
The court followed the four conclusions reached in Sykes (another Eastern District of Pennsylvania case) - and an opinion we also liked.Allowing case-by-case inquiries into whether a particular vaccine is unavoidably unsafe would do nothing to protect vaccine manufacturers from suit from design defects, as congress intended.Congress also intended to provide an umbrella under which manufacturers would improve the safety of their products while remaining immune from design defect claims made possible… [read post]
27 Sep 2011, 9:59 am
What we do here sometimes affects other types of cases, and what goes on in other types of cases certainly can have significant impact on our clients.One of the other things that Bexis does around here to make himself useful is to prepare monthly memoranda that summarize newly decided cases involving Pennsylvania tort and product liability law generally (he's a glutton for punishment). [read post]
3 Jan 2011, 5:49 am
Bexis is a smart lawyer, so that's what he did on Friday, emphasizing the Montana Supreme Court's reaffirmation of the learned intermediary rule.And now we must confront the ugly bits in the opinion.Before we do that, let's confess to a smidgen of exasperation. [read post]
24 Aug 2011, 8:25 am
Super. 2001) (yup, Bexis and Michelle did that one). [read post]
12 Sep 2012, 5:00 am
Bexis would be Sinatra, Sullivan would be Dino, Yeary would be Shirley MacLaine, leaving your current scribe as … Joey Bishop. [read post]
31 Dec 2015, 5:12 am
When we (well, Bexis) started advocating the First Amendment as a defense in the off-label promotion context twenty years ago, there wasn’t much traction. [read post]
14 May 2015, 7:28 am
” Since Bexis’ 1998 law review article popularized the now-overwhelmingly adopted position that informed consent includes medical risks, not regulatory matters such as off-label use, we are particularly interested in patrolling that boundary. [read post]
